Calliditas Therapeutics AB (publ) (CALT) News Today $40.00 0.00 (0.00%) As of 07/7/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock CALT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period 16,117 Shares in Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Bought by Crossmark Global Holdings Inc.November 16, 2024 | marketbeat.comCalliditas Therapeutics to Present Four Abstracts at American Society of Nephrology (ASN) Kidney Week 2024October 17, 2024 | tmcnet.comCalliditas Therapeutics (NASDAQ:CALT) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Reaches New 52-Week High at $43.00September 20, 2024 | marketbeat.comDelisting of Calliditas Therapeutics AB (publ) from Nasdaq StockholmSeptember 16, 2024 | prnewswire.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Short Interest Down 60.7% in AugustSeptember 13, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Sets New 12-Month High at $41.91September 3, 2024 | marketbeat.comNotice of extraordinary meeting of Calliditas Therapeutics AB (publ)September 3, 2024 | prnewswire.comCalliditas Therapeutics takes certain corporate actions following announcement by Asahi KaseiSeptember 3, 2024 | prnewswire.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Large Growth in Short InterestAugust 31, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Large Volume IncreaseAugust 27, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Unusually-High Trading VolumeAugust 15, 2024 | marketbeat.comShort Interest in Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Drops By 23.8%August 15, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Issues Quarterly Earnings ResultsAugust 14, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Receives Consensus Rating of "Hold" from BrokeragesAugust 14, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | seekingalpha.comCalliditas Therapeutics (spons ADRs) earnings: here's what Wall Street expectsAugust 13, 2024 | markets.businessinsider.comCalliditas Interim Report January to June 2024August 13, 2024 | prnewswire.comLC8.SG,0P0001K80V,0 (LC8.SG)August 12, 2024 | ca.finance.yahoo.comCalliditas Therapeutics AB (publ) (CALT) Set to Announce Earnings on TuesdayAugust 6, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Trading Up 1.2%August 5, 2024 | marketbeat.comCalliditas Therapeutics to Attend 2024 Women in Nephrology (WIN) Leadership ConferenceAugust 1, 2024 | markets.businessinsider.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Strong Trading VolumeAugust 1, 2024 | marketbeat.comNumber of shares and votes in Calliditas TherapeuticsJuly 31, 2024 | prnewswire.comSTOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger and its Tender Offer for Calliditas Therapeutics AB – CALTJuly 27, 2024 | globenewswire.comSTOCKHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring August 30, 2024, for shares of Calliditas Therapeutics AB - CALTJuly 26, 2024 | prnewswire.comCALT Aug 2024 40.000 call (CALT240816C00040000)July 26, 2024 | finance.yahoo.comCalliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitisJuly 26, 2024 | prnewswire.comCalliditas Therapeutics AB (publ) (LC8A.F)July 20, 2024 | nz.finance.yahoo.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Given Consensus Rating of "Hold" by AnalystsJuly 20, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Short Interest Up 13.4% in JuneJuly 15, 2024 | marketbeat.comLaunch of Phase 3 clinical trial with Nefecon in JapanJuly 4, 2024 | prnewswire.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Given Average Recommendation of "Hold" by AnalystsJune 25, 2024 | marketbeat.comCalliditas provides setanaxib patent updateJune 18, 2024 | prnewswire.comBulletin from the annual general meeting of Calliditas Therapeutics AB (publ)June 17, 2024 | prnewswire.comShort Interest in Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Declines By 16.3%June 15, 2024 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT, SGE on Behalf of ShareholdersJune 7, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 18, 2024, for shares of Calliditas Therapeutics AB – CALTJune 5, 2024 | globenewswire.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 18, 2024, for shares of Calliditas Therapeutics AB - CALTJune 4, 2024 | prnewswire.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Hits New 52-Week High at $40.49June 4, 2024 | marketbeat.comShort Interest in Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Rises By 12.6%June 1, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Given Consensus Recommendation of "Hold" by BrokeragesMay 31, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Stock Rating Reaffirmed by CitigroupMay 31, 2024 | marketbeat.comCalliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathyMay 30, 2024 | prnewswire.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Shares Gap Up to $37.94May 30, 2024 | marketbeat.comCalliditas Therapeutics AB (publ) (NASDAQ:CALT) Downgraded by Lifesci CapitalMay 30, 2024 | marketbeat.comSwedish Exchange Growth Leaders: 3 Companies With Significant Insider OwnershipMay 28, 2024 | finance.yahoo.comMaintaining Hold on Calliditas: Assessing Acquisition Fairness Amid Evolving IgAN Market DynamicsMay 28, 2024 | markets.businessinsider.comJefferies Financial Group Reiterates Hold Rating for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)May 28, 2024 | marketbeat.com Get Calliditas Therapeutics AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for CALT and its competitors with MarketBeat's FREE daily newsletter. Email Address CALT Media Mentions By Week CALT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CALT News Sentiment▼0.000.57▲Average Medical News Sentiment CALT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CALT Articles This Week▼01▲CALT Articles Average Week Get Calliditas Therapeutics AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for CALT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Akero Therapeutics News ADMA Biologics News Vaxcyte News Krystal Biotech News Rhythm Pharmaceuticals News Cytokinetics News PTC Therapeutics News Zai Lab News ACADIA Pharmaceuticals News Merus News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CALT) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CALT Stock Alerts